PRODUCTION OF HYPERIMMUNE SERUM AGAINST RECOMBINANT PROTEINS SODC AND OMP16 OF BRUCELLA SPP. FOR THE DEVELOPMENT OF AN ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TEST SYSTEM
Main Article Content
Authors
N.K. Orazymbetova
LLP “Research Institute for Biological Safety Problems” of the National Holding “QazBioPharm”
Zh.K. Koshemetov
LLP “Research Institute for Biological Safety Problems” of the National Holding “QazBioPharm”
O.V. Chervyakova
LLP “Research Institute for Biological Safety Problems” of the National Holding “QazBioPharm”
B.K. Umuraliev
LLP “Research Institute for Biological Safety Problems” of the National Holding “QazBioPharm”
O.N. Serikbaiov
LLP “Research Institute for Biological Safety Problems” of the National Holding “QazBioPharm”
V.Zh. Kaukarbaeva
LLP “Research Institute for Biological Safety Problems” of the National Holding “QazBioPharm”
A.A. Issakhan
LLP “Research Institute for Biological Safety Problems” of the National Holding “QazBioPharm”
A.K. Adalbekova
LLP “Research Institute for Biological Safety Problems” of the National Holding “QazBioPharm”
A.U. Issabek
LLP “Research Institute for Biological Safety Problems” of the National Holding “QazBioPharm”
A.K. Bopi
LLP “Research Institute for Biological Safety Problems” of the National Holding “QazBioPharm”
Abstract
Brucellosis is a widespread zoonotic disease transmitted from domestic animals to humans and is endemic in many regions of the world. There is a need for highly specific serological tests for brucellosis based on recombinant proteins to reduce cross-reactivity with other Gram-negative bacteria and to differentiate between vaccinated and infected individuals. The aim of the present study was to obtain hyperimmune sera against Brucella spp. antigens in laboratory animals. Rabbits and guinea pigs were used as experimental animals. For immunization, recombinant Brucella spp. proteins Omp16 and SodC were used in combination with adjuvants, including aluminum hydroxide (Al(OH)₃), as well as complete and incomplete Freund’s adjuvant (CFA/IFA). Immunization was performed according to a standard protocol, followed by monitoring of antibody levels in blood sera using enzyme-linked immunosorbent assay (ELISA) and agar gel precipitation test (AGPT). For protein expression, producer strains were cultured in LB medium supplemented with kanamycin. Protein synthesis was induced with 0.1 mM IPTG. Purification was performed using immobilized metal affinity chromatography (IMAC).
As a result of the study, hyperimmune sera with a high level of specific antibodies were obtained. It was demonstrated that the use of adjuvants promotes the development of a pronounced humoral immune response in immunized animals. The highest antibody titers were observed in animals immunized with CFA/IFA adjuvants, where antibody titers reached 1:6400 in rabbits and 1:1600 in guinea pigs. When aluminum hydroxide was used, antibody titers were 1:3200 and 1:800 in rabbits and guinea pigs, respectively.
The obtained results confirm the effectiveness of the proposed approach for producing hyperimmune sera and demonstrate their potential for use as reference positive controls in the development and standardization of serological methods for brucellosis diagnostics.
Keywords
recombinant proteins SodC and Omp16, immunogenicity, hyperimmune serum, enzyme-linked immunosorbent assay (ELISA), immunization
Article Details
References
Taipova A.A., Beishova I.S., Alikhanov K.D., Otarbayev V.K.,Ulyanov V.A., Ginayatov N.S.,Dushaeva L. Zh. Monitoring of the epizootic situation on animal brucellosis in the republic of Kazakhstan. // Nauka i obrazovanie. – 2023. No. 2 (71) – P. 161–169. – DOI: Crossref.
Qureshi K.A., Parvez A., Fahmy N.A., Abdel Hady B.H., Kumar S., Ganguly A., Atiya A., Elhassan G.O., Alfadly S.O., Parkkila S., Aspatwar A. Brucellosis: epidemiology, pathogenesis, diagnosis and treatment-a comprehensive review. // Ann Med. – 2024. –Vol. 55, No.2. – P. 2295398. – DOI: 10.1080/07853890.2023.2295398. PMID: 38165919; PMCID: PMC10769134.
Ismail A.A., Angara T.E., Ibrahim A.M. Knowledge, Attitudes and Practices Associated with Brucellosis in Small-holder Dairy Farms in Suburbs of Khartoum State, Sudan //EC Veterinary Science. – 2019. – T. 4. – P. 241-50.
Laine C.G., Johnson V.E., Scott H.M., Arenas-Gamboa A.M. Global Estimate of Human Brucellosis Incidence.// Emerg Infect Dis. – 2023 Sep. – Vol. 29. – No. 9. P. – 1789-1797. – DOI: 10.3201/eid2909.230052. PMID: 37610167; PMCID: PMC10461652.
Kasymov E., Isabaev A., Oshakbaeva N., Aubakirov M., Erenko E., Rakeckij V., Sharipova A. Monitoring jepizooticheskoj situacii brucelljoza sredi zhivotnyh i ljudej v Kostanajskoj oblasti // Nauka i obrazovanie. – 2025. – T. 2, № 3(80). – S. 29–41. – Rezhim dostupa: URL (data obrashhenija: 21.03.2026).
Golchin, M., Mollayi, S., Mohammadi, E. et al. Serodiagnosis of human brucellosis by an indirect ELISA test using recombinant outer membrane protein 19 kDa (rOMP19) as an antigen. BMC Biotechnol 23, 46 (2023). Crossref.
Tailakova E. T., Sadikaliyeva S.O., Shynybekova G.O., Abubakirova A.K., Sultankulova K.T., Chervyakova O.V. Construction, expression and purification of brucella spp. recombinant proteins L7/L12 and SodC in E. coli / News of the national academy of sciences of the republic of Kazakhstan. // – 2020. – Vol. 1, No. 337. ISSN 2224-5308. –P. 20 – 30. – DOI: Crossref.
Lukert, P.D., Saif, Y.M., Glisson, J.R., Fadly, A.M., McDougald, L.R. and Swayne, D.E. Infectious bursal disease. // Disease of Poultry. 11th Ed., Iowa State University, Ames, Iowa, USA. – 2003. – P. 161-179.
Pirhajati R., Chiani M., Habibi M., Emami T., Shahrokhi N., Asadi Karam M.R. Successful prophylactic against Brucella melitensis using a vaccine candidate consisting of recombinant antigens OMP19 and L7/L12 loaded in a nanoliposomal adjuvant system in a mouse model. // Int J Pharm. – 2026. – P. 687. – P:126372. – DOI: 10.1016/j.ijpharm.2025.126372. PMID: 41218729.)
Bugybayeva D., Ryskeldinova S., Zinina N., Sarmykova M., Assanzhanova N., Kydyrbayev Z., Tabynov K. Development of Human Vectored Brucellosis Vaccine Formulation: Assessment of Safety and Protectiveness of Influenza Viral Vectors Expressing Brucella Immunodominant Proteins in Mice and Guinea Pigs. // Biomed Res Int. – 2020. No.19. – P:1438928. – DOI: 0.1155/2020/1438928. PMID: 33274194; PMCID: PMC7695499.
Cassataro J., Oliveira S. C., Giambartolomei G. H. Outer membrane proteins and recombinant antigens of Brucella: advances in vaccine and diagnostic development // FEMS Immunology & Medical Microbiology. – 2011. – Vol. 61, № 3. – P. 211–223.
Atapour A., Mostafavi-Pour Z., Mokarram P., Mohammadi S. Cloning, expression and purification of a novel fusion protein composed of flagellin and NS5B of hepatitis C virus in Escherichia coli host // Shiraz E-Medical Journal. – 2018. – Vol. 20, № 1. – DOI: 10.5812/semj.79898.
Lim J. J., Kim D. H., Lee J. J., Kim D. G., Min W., Lee W. J. et al. Protective effects of recombinant Brucella abortus Omp28 against infection with a virulent strain of Brucella abortus 544 in mice // Journal of Veterinary Science. – 2012. – Vol. 13, № 3. – P. 287–292.
Ergin A., Büssow K., Sieper J. et al. Homologous high-throughput expression and purification of highly conserved E. coli proteins // Microbial Cell Factories. – 2007. – Vol. 6, № 1. – P. 18. – DOI: 10.1186/1475-2859-6-18.
Ganesan M., Jagannathan R., Girija K., Joseph R. Gnaniah. An improvised 10-min rapid Lowry’s protein estimation for clinical samples // Research Journal of Biotechnology. – 2025. – Vol. 20, № 4. – P. 191–195. – DOI: 10.25303/204rjbt1910195.
GraphPad Software. GraphPad Prism version 8.0 for Windows. San Diego, California, USA. – 2026. – Available at: URL (accessed: 2026).
Motulsky H. Intuitive Biostatistics: A Nonmathematical Guide to Statistical Thinking. 4th ed. – Oxford: Oxford University Press, 2018.
Gorvel J. P. Brucella: a Mr “Hide” converted into Dr. Jekyll // Microbes and Infection. – 2008. – Vol. 10, № 10. – P. 1010–1017.
Letesson J. J., Tibor A., van Eynde G., Wansard V., Weynants V., Denoel P., Saman E. Humoral immune responses of Brucella-infected cattle, sheep, and goats to eight purified recombinant Brucella proteins in an indirect enzyme-linked immunosorbent assay // Clinical and Diagnostic Laboratory Immunology. – 1997. – Vol. 4, № 5. – P. 556–564. – DOI: 10.1128/cdli.4.5.556-564.1997. – PMID: 9302205. – PMCID: PMC170595.
Sung K. Y., Jung M., Shin M. K., Park H. E., Lee J. J., Kim S., Yoo H. S. Induction of immune responses by two recombinant proteins of Brucella abortus, outer membrane proteins 2b porin and Cu/Zn superoxide dismutase, in mouse model // Journal of Microbiology and Biotechnology. – 2014. – Vol. 24, № 6. – P. 854–861. – DOI: 10.4014/jmb.1312.12063. – PMID: 24608566.